CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- 4 Planned sale Chief Executive Officer sold 25,000 shares at $6.52 ($162,925)
- 4 Open-market buy Chief Innovation Officer bought 3,000 shares at $4.93 ($14,790)
- 4 Grant or award Chief Technology Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 24,835 shares (grant or award)
- 4 Grant or award Director acquired 16,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Director acquired 500 shares (code W)
- 4 Grant or award General Counsel & CCO acquired 56,250 shares (grant or award)
- 4 Grant or award Principal Accounting Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Innovation Officer acquired 30,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 4 Grant or award Chief Acquisition Officer acquired 75,000 shares (grant or award)
- 4 Other acquisition Director acquired 750 shares (code W)
- 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
- 4 Option exercise Director acquired 37,500 shares (option exercise)
- 4/A Open-market buy Director bought 73,965 shares at an average $2.49 ($183,922)
- 4 Open-market buy Director bought 132,072 shares at an average $3.79 ($501,018)
- 4 Grant or award Director acquired 70,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award President acquired 100,000 shares (grant or award)
Page 4 of 12 · 230 filings